US4835186A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Spray dried ibuprofen
Assignee: Wyeth LLC
•
Filing: 1987-06-15
•
Granted: 1989-05-30
•
Expires: 2007-06-15
Abstract
Abstract A therapeutic taste-neutral powder form of ibuprofen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of ibuprofen and cellulose acetate phthalate.
Inventors
- 👤 Gerald L. Reuter
- 👤 Maureen M. Harrison
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 23:56
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0056; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1652; A61K9/1611
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
82 words
A therapeutic taste neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of cellulose acetate phthalate and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol being mixed with up to 50% ethyl acetate.
Claim 2
Dependent Claim
82 words
A therapeutic taste neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of cellulose acetate phthalate and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol being mixed with up to 50% ethyl acetate.
Claim 3
Dependent Claim
116 words
In a pharmaceutical dosage form for oral administration as a solid, which dosage form can be disintegrated by water within ten seconds, the improvement which comprises incorporating into such dosage form as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of acetate phthalate cellulose and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol being mixed with up to 50% ethyl acetate.
Claim 4
Dependent Claim
116 words
In a pharmaceutical dosage form for oral administration as a solid, which dosage form can be disintegrated by water within ten seconds, the improvement which comprises incorporating into such dosage form as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% by weight ibuprofen, about 15% to 50% by weight of acetate phthalate cellulose and about 5% to 40% by weight colloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose material, the lower alkanol being mixed with up to 50% ethyl acetate.
Claim 5
Dependent Claim
14 words
The taste neutral powder of claim 1 wherein the lower alkanol is isopropyl alcohol.
Claim 6
Dependent Claim
13 words
The dosage form of claim 2 wherein the lower alkanol is isopropyl alcohol.
Claim 7
Dependent Claim
106 words
In a pharmaceutical dosage form for oral administration as a solid chewable taste-neutral tablet containing ibuprofen, the improvement which comprises incorporating into such tablet as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% ibuprofen, about 15% to 50% by weight of cellulose acetate phthalate, and about 5% to 40% by weight cooloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose acetate phthalate, the lower alkanol containing up to 50% ethyl acetate.
Claim 8
Dependent Claim
106 words
In a pharmaceutical dosage form for oral administration as a solid chewable taste-neutral tablet containing ibuprofen, the improvement which comprises incorporating into such tablet as the pharmaceutical substance a therapeutic taste-neutral powder form of spray-dried ibuprofen which consists essentially of, based upon the weight of the powder, about 40% to 70% ibuprofen, about 15% to 50% by weight of cellulose acetate phthalate, and about 5% to 40% by weight cooloidal silica, the powder having been spray dried from a suspension of the colloidal silica in a lower alkanol solution of the ibuprofen and the cellulose acetate phthalate, the lower alkanol containing up to 50% ethyl acetate.
Claim 9
Dependent Claim
13 words
The dosage form of claim 5 wherein the lower alkanol is isopropyl alcohol.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-05-29 | 1992-11-28 | 1993-05-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-05-29 | 1996-11-28 | 1997-05-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-05-29 | 2000-11-28 | 2001-05-30 | $7700.00 | Window Closed / Lapsed |